Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Surg Res ; 296: 155-164, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38277952

RESUMEN

INTRODUCTION: Breast cancer, although the second most common malignancy in women in the United States, is rare in patients under the age of 40 y. However, this young patient population has high recurrence and mortality rates, with chemotherapy frequently used as adjuvant treatment. We aimed to determine whether age is an independent predictor of chemotherapy recommendation and subsequent treatment and the relationship to Oncotype Dx (ODX) recurrence score (RS). METHODS: The National Cancer Database was retrospectively reviewed from 2010-2016 to identify women with early-stage (pT1-pT3, pN0-pN1mic, M0), hormone receptor positive, human epidermal growth factor receptor 2 negative breast cancer who underwent ODX RS testing. RESULTS: Of 95,382 patients who met the inclusion criteria, risk groups using the traditional ODX RS cutoffs were 59% low, 33% intermediate, and 8% high. Using Trial Assigning Individualized Options for Treatment RS cutoffs, risk groups were 23% low, 62% intermediate, and 15% high. Chemotherapy recommendation decreased as age at diagnosis increased (P < 0.001). Increasing age was associated with decreased odds of chemotherapy recommendation in univariate models both continuously (odds ratio: 0.98, 95% confidence interval 0.97-0.98; P < 0.001) and categorically by decade (P < 0.001). Age by decade remained an independent prognosticator of chemotherapy recommendation (P < 0.001), adjusted for risk groups. CONCLUSIONS: Chemotherapy recommendation and treatment differs by age among patients with early-stage hormone receptor positive breast cancer who undergo ODX testing. While molecular profiling has been shown to accurately predict the benefit of chemotherapy, younger age at diagnosis is a risk factor for discordant use of ODX RS for treatment strategies in breast cancer; with patients aged 18-39 disproportionately affected.


Asunto(s)
Neoplasias de la Mama , Humanos , Femenino , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Pronóstico , Estudios Retrospectivos , Perfilación de la Expresión Génica , Quimioterapia Adyuvante , Recurrencia Local de Neoplasia/epidemiología
3.
J Assoc Genet Technol ; 46(4): 244-249, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33293489

RESUMEN

OBJECTIVES: Objective: Host genetics can influence susceptibility to Chlamydia trachomatis infection. This study examined two genetic variants in human protein disulfide isomerase A2 (PDIA2), a member of a family of protein chaperones that participate in the chlamydial life cycle. Methods: A total of 278 male and female subjects, positive or negative for C. trachomatis infection, were genotyped for PDIA2 polymorphisms (rs400037 and rs419949) using real-time PCR and pyrosequencing. Results: There was a significant odds ratio of 8.21 (95% CI: 1.77-38.16) for rs400037 and 9.89 (95% CI: 1.19-82.10) for rs419949, for the AA genotypes. Conclusion: This indicates that individuals with the PDIA2 AA genotypes have significantly increased susceptibility to C. trachomatis infection as compared to the other PDIA2 genotypes (GG, GA). This correlation may be explained by an interactive role of host protein disulfide isomerases in the attachment and entry of C. trachomatis into cells.

4.
Oral Oncol ; 78: 145-150, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29496042

RESUMEN

OBJECTIVES: In accordance with the Precision Medicine Initiative, new treatment strategies for head and neck squamous cell carcinoma (HNSCC) are needed to yield better therapeutic outcomes. The purpose of this study was to establish and validate chimeric antigen receptor (CAR)-T cells targets in HNSCC. METHODS: Putative CAR-T antigens were identified in The Cancer Genome Atlas database. To validate antigen suitability, quantitative RT-PCR, flow cytometry, and immunofluorescent staining were performed. A retroviral human CD70 CAR construct, using truncated CD27 conjugated with 4-1BB and CD3-zeta costimulatory molecules, was used to transduce activated human T cells to generate CD70 CAR-T cells. Cell-based cytotoxicity and cytokine ELISAs were used to measure efficacy of killing. RESULTS: Nine potential CAR-T targets (CD276, EGFR, MICA, MICB, MAGE-A4, FAP, EPCAM, CD70, B4GALNT1) were identified based on their high expression in tumors compared to flanking control tissues. CD70 was selected for further proof-of-principle analysis based on its differential expression in several tumor subtypes, and showed substantial heterogeneity in individual tumors analyzed. Cell surface CD70 protein and CD70 mRNA were detected from low to high levels in established HNSCC cancer cell lines. CD70 was highly expressed in 4 of 21 tumor biopsies (19%), and 3 of 4 specimens showed strong CD70 expression on the tumor cell surface. CD70-specific CAR-T cells were generated and further demonstrated to recognize and kill CD70-positive HNSCC cells efficiently, but not CD70-negative cancer cells. CONCLUSION: CD70-specific CAR-T cells specifically recognized and efficiently eliminated CD70-positive HNSCC cells. This study provides the basis for further investigation into CD70 and other CAR-T targets.


Asunto(s)
Ligando CD27/metabolismo , Neoplasias de Cabeza y Cuello/inmunología , Receptores Quiméricos de Antígenos/metabolismo , Carcinoma de Células Escamosas de Cabeza y Cuello/inmunología , Linfocitos T/inmunología , Humanos
5.
Can J Public Health ; 108(4): e421-e426, 2017 Nov 09.
Artículo en Inglés | MEDLINE | ID: mdl-29120316

RESUMEN

Vision-screening programs are designed to detect common causes of visual impairment and increase the likelihood of early diagnosis and treatment. In the health authority Eastern Health - Newfoundland and Labrador, public health leaders raised a concern about the efficiency and effectiveness of the current non-routine, opportunistic vision screening protocol for school-aged children. An environmental scan of screening practices and programs across Canada was conducted, yielding a wide range of inconsistencies with respect to program type, target population, and screening tools. A significant gap in evidence-based research into universal vision-screening programs for the school-aged population (6+) was also noted. In light of these findings (both in practice and research), we recommend that researchers and public health practitioners across the country evaluate their current practice with respect to school-based vision screening and disseminate their findings through publication. We conclude that evaluation and research into current school-based screening programs (both opportunistic and universal) will provide the evidence needed to guide practice.


Asunto(s)
Servicios de Salud Escolar , Trastornos de la Visión/diagnóstico , Selección Visual/métodos , Canadá , Niño , Práctica Clínica Basada en la Evidencia , Humanos
8.
Clin Med (Lond) ; 15(5): 465-7, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26430187

RESUMEN

The management of diabetes in older people is often challenging and poorly researched. The prevalence of cognitive impairment, chronic kidney disease and other co-existing comorbidities increase with age and have a significant impact on glycaemic control targets and treatment options. This conference examined current clinical practice, highlighted differences in the management of diabetes in the older person and suggested potential areas of future research.


Asunto(s)
Complicaciones de la Diabetes , Diabetes Mellitus/terapia , Anciano , Glucemia/análisis , Diversidad Cultural , Demencia/etiología , Cetoacidosis Diabética/terapia , Nefropatías Diabéticas/terapia , Anciano Frágil , Humanos , Hiperglucemia/etiología , Coma Hiperglucémico Hiperosmolar no Cetósico/terapia , Atención Perioperativa
9.
J Mol Diagn ; 16(3): 288-96, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24745724

RESUMEN

Molecular diagnostics is a rapidly growing specialty in the clinical laboratory assessment of pathology. Educational programs in medical laboratory science and specialized programs in molecular diagnostics must address the training of clinical scientists in molecular diagnostics, but the educational curriculum for this field is not well defined. Moreover, our understanding of underlying genetic contributions to specific diseases and the technologies used in molecular diagnostics laboratories change rapidly, challenging providers of training programs in molecular diagnostics to keep their curriculum current and relevant. In this article, we provide curriculum recommendations to molecular diagnostics training providers at both the baccalaureate and master's level of education. We base our recommendations on several factors. First, we considered National Accrediting Agency for Clinical Laboratory Sciences guidelines for accreditation of molecular diagnostics programs, because educational programs in clinical laboratory science should obtain its accreditation. Second, the guidelines of several of the best known certifying agencies for clinical laboratory scientists were incorporated into our recommendations. Finally, we relied on feedback from current employers of molecular diagnostics scientists, regarding the skills and knowledge that they believe are essential for clinical scientists who will be performing molecular testing in their laboratories. We have compiled these data into recommendations for a molecular diagnostics curriculum at both the baccalaureate and master's level of education.


Asunto(s)
Personal de Laboratorio Clínico/educación , Patología Molecular/educación , Servicios de Laboratorio Clínico , Habilitación Profesional , Curriculum , Humanos , Técnicas de Diagnóstico Molecular/métodos , Patología Molecular/métodos
10.
Mol Cell Biochem ; 352(1-2): 143-54, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21359964

RESUMEN

The organic cation transporter (OCT, SLC22) family is a family of polyspecific transmembrane proteins that are responsible for the uptake or excretion of many cationic drugs, toxins, and endogenous metabolites in a variety of tissues. Many of the OCTs have been previously characterized, but there are a number of orphan genes whose functions remain unknown. In this study, two novel rat SLC22 genes, SLC22A17 (BOCT1) and SLC22A23 (BOCT2), were cloned and characterized. Northern blot analysis showed that BOCT1 and BOCT2 mRNA was expressed in a wide variety of tissues. BOCT1 was strongly expressed in brain, primary neurons and brain endothelial cells, with highest expression in choroid plexus. BOCT2 was also abundantly expressed in brain, as well as in liver. To characterize the products of these genes, BOCT1 cDNA was isolated from a rat blood-brain barrier cDNA library, and BOCT2 cDNA was isolated from rat brain capillary and from cultured neurons using PCR techniques. Plasmids expressing BOCT1 and BOCT2 were transfected into HEK-293 cells, as were control cDNAs for OCT1 and OCTN2. Recombinant cell surface protein was verified by western blot and fluorescence microscopy. Transport activity of BOCT1 and BOCT2 was evaluated using radioisotope uptake assays. The OCT1- and OCTN2-expressing cells transported the canonical substrates, 1-methyl-4-phenyl-pyridinium (MPP(+)) and carnitine, respectively. However, BOCT1 and BOCT2-expressing cells did not show transport activity for these substrates or a number of other SLC22 substrates. These novel family members have a nonconserved amino terminus, relative to other OCTs, that may preclude typical SLC22 transport function.


Asunto(s)
Proteínas de Transporte de Catión Orgánico/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Western Blotting , Cartilla de ADN , ADN Complementario , Microscopía Fluorescente , Datos de Secuencia Molecular , Proteínas de Transporte de Catión Orgánico/química , ARN Mensajero/genética , Ratas , Homología de Secuencia de Aminoácido
11.
J Assoc Genet Technol ; 37(1): 21-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21430352

RESUMEN

Breast cancer is the most common form of cancer in women. Despite extensive study, the etiology of breast cancer remains ambiguous. A group of genetic modifiers known as microRNAs (miRNAs) are emerging onto the scene of breast cancer research. MicroRNAs are small, non-coding RNAs that are involved in the regulation of key cellular processes such as proliferation, differentiation, and apoptosis. They can interfere directly with the translation and stability of a targeted gene transcript and cause a disturbance in the cell physiology. The dysregulation of both oncogenes and tumor suppressor genes by aberrant miRNA production can result in the progression to breast cancer. This review provides a discussion of the nature of miRNAs, explains the role of miRNAs in the etiology and progression of breast cancer, and discusses their potentials as therapeutic molecules and diagnostic markers.

12.
J Dent Hyg ; 85(4): 256-63, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22309866

RESUMEN

Dental biofilms are complex, multi-species bacterial communities that colonize the mouth in the form of plaque and are known to cause dental caries and periodontal disease. Biofilms are unique from planktonic bacteria in that they are mutualistic communities with a 3-dimensional structure and complex nutritional and communication pathways. The homeostasis within the biofilm colony can be disrupted, causing a shift in the bacterial composition of the colony and resulting in proliferation of pathogenic species. Because of this dynamic lifestyle, traditional microbiological techniques are inadequate for the study of biofilms. Many of the bacteria present in the oral cavity are viable but not culturable, which severely limits laboratory analysis. However, with the advent of new molecular techniques, the microbial makeup of oral biofilms can be better identified. Some of these techniques include DNA-DNA hybridization, 16S rRNA gene sequencing, denaturing gradient gel electrophoresis, terminal restriction fragment length polymorphism, denaturing high-performance liquid chromatography and pyrosequencing. This review provides an overview of biofilm formation and examines the major molecular techniques currently used in oral biofilm analysis. Future applications of the molecular analysis of oral biofilms in the diagnosis and treatment of caries and periodontal disease are also discussed.


Asunto(s)
Bacterias/clasificación , Biopelículas , Placa Dental/microbiología , Boca/microbiología , Bacterias/genética , Diagnóstico Bucal , Técnicas Genéticas , Humanos , Biología Molecular , Hibridación de Ácido Nucleico , Análisis de Secuencia de ARN
13.
Neurochem Res ; 34(2): 205-14, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18483854

RESUMEN

Basal forebrain cholinergic neurons (BFCNs) degenerate in aging and Alzheimer's disease. It has been proposed that estrogen can affect the survival and function of BFCNs. This study characterized primary rat BFCN cultures and investigated the effect of estrogen on high-affinity choline uptake (HACU). BFCNs were identified by immunoreactivity to the vesicular acetylcholine transporter (VAChT) and represented up to 5% of total cells. HACU was measured in living BFCN cultures and differentiated from low-affinity choline uptake by hemicholinium-3 (HC-3) inhibition. A HC-3 concentration curve showed that 0.3 muM HC-3, but not higher concentrations that inhibit LACU, could distinguish the two transport activities. 17-beta-Estradiol treatment increased HACU in some culture preparations that contained non-neuronal cells. Elimination of dividing cells using antimitotic treatments resulted in a lack of estrogen effects on HACU. These results suggest that estrogen may have indirect effects on BFCNs that are mediated through non-neuronal cells.


Asunto(s)
Colina/metabolismo , Estrógenos/farmacología , Prosencéfalo/efectos de los fármacos , Animales , Secuencia de Bases , Células Cultivadas , Cartilla de ADN , Inmunohistoquímica , Prosencéfalo/citología , Prosencéfalo/metabolismo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...